The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis.

Saved in:
Bibliographic Details
Title: The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis.
Authors: Wells M; Department of Clinical Specialties and Related Sciences, University of Bristol, Bristol, UK.; Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, UK.; Department of Rheumatology, North Bristol NHS Trust, Bristol, UK., Smith T; Department of Mathematical Sciences, University of Bath, Bath, UK., Domsic RT; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA., Anilkumar A; Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, UK., Frech TM; Vanderbilt University, Nashville, TN, USA., Herrick AL; Centre for Musculoskeletal Research, University of Manchester, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.; National Institute for Health and Care Research (NIHR), Manchester Biomedical Research Centre, Manchester, UK., Hummers LK; Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Shah AA; Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Denton CP; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital, London, UK., Khanna D; University of Michigan Scleroderma Program, Ann Arbor, MI, USA.; Division of Rheumatology, University of Michigan, Ann Arbor, MI, USA., Barratt SL; Department of Clinical Specialties and Related Sciences, University of Bristol, Bristol, UK.; Academic Respiratory Unit, Department of Clinical Sciences, University of Bristol, Bristol, UK., Pauling JD; Department of Clinical Specialties and Related Sciences, University of Bristol, Bristol, UK.; Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, UK.; Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, Bristol, UK.
Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2026 Jun 03; Vol. 65 (6).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1462-0332
DOI:10.1093/rheumatology/keag267